• Bullish Stocks
  • Bearish Stocks
  • Volume Shockers
  • Top Gainers
    • Daily Gainers
    • Weekly Gainers
    • Monthly Gainers
  • Top Losers
    • Daily Losers
    • Weekly Losers
    • Monthly Losers
  • Intraday Calls
  • Screeners
    • Multibagger Stocks
    • NR 7 + IB Stocks
    • Narrow CPR Stocks
0 Items
Daily Stock Tips
  • Home
  • Cryptocurrency Ranking
  • News
  • Technical Trader
  • Giveaway
  • Advertise
  • Contact us
Select Page
Moderna, Inc.

Quotes, news, charts and market data on Moderna, Inc.. Find all information needed below.

 

Last updated: 1 day ago

 

Back to Screener
MRNA
Moderna, Inc.
NasdaqGS
$150.88
1.46
0.98%
asset

EQUITY

Asset Class

industry

Healthcare

Sector

Asset Country

United States

Country

industry

Biotechnology

Industry

AMZN 
$98.13  -0.59%  
GOOG 
$106.06  -0.19%  
MSFT 
$280.57  1.05%  
TSLA 
$190.41  -0.94%  
 
$0.0000  0.00%  
NFLX 
$328.39  2.50%  
PFE 
$40.39  0.52%  
BRK-A 
$453,066.12  0.07%  
AAPL 
$160.25  0.83%  
BABA 
$86.90  0.44%  
 
$0.0000  0.00%  
PYPL 
$73.88  1.82%  
KO 
$60.90  1.64%  
V 
$221.04  -0.70%  
MRNA 
$150.88  0.98%  
JPM 
$124.91  -1.52%  
WMT 
$141.80  0.82%  
SQ 
$60.68  -1.94%  

Moderna, Inc. stock price: $150.88  ($1.46 $1.46)

Open: $149.74 Low: $149.01  High: $152.57 Close: $149.42

Moderna, Inc. stock exchange: 

NMS

Moderna, Inc. market capitalization: 

$58.19B

Moderna, Inc. dividend rate:

  %

Moderna, Inc. dividend yield: 

%

Moderna, Inc. outstanding shares: 

385.68M

Moderna, Inc. EPS: 

20.23

Moderna, Inc.

Market Data

Moderna, Inc.
Status: Active
Industry: Biotechnology
Exchange: NMS
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Trade. Smarter. Better.

Daily Stock Tips

Daily Stock Tips provides you with market data across asset classes. Ranging from Indian & other stocks, commodities, cryptocurrencies and more.

None of the content is financial advice.

© 2020 dailystocktips.co.in

Resources

Daily Stock Tips 2.0
News Corner
Stocks & Commodities
Cryptocurrency Ranking
Bullish Stocks (India)
Bearish Stocks (India)
Bullish Stocks (India)
Top Gainers (India)

About Us

Contact
Twitter
Facebook
AMZN 
$98.13  -0.59%  
GOOG 
$106.06  -0.19%  
MSFT 
$280.57  1.05%  
TSLA 
$190.41  -0.94%  
 
$0.0000  0.00%  
NFLX 
$328.39  2.50%  
PFE 
$40.39  0.52%  
BRK-A 
$453,066.12  0.07%  
AAPL 
$160.25  0.83%  
BABA 
$86.90  0.44%  
 
$0.0000  0.00%  
PYPL 
$73.88  1.82%  
KO 
$60.90  1.64%  
V 
$221.04  -0.70%  
MRNA 
$150.88  0.98%  
JPM 
$124.91  -1.52%  
WMT 
$141.80  0.82%  
SQ 
$60.68  -1.94%